Latest Articles

  • Sustainable Procurement in Drug Design: Bridging the Data Gap

    Pharmaceutical companies face growing pressure to design more sustainable drugs and report their impacts in greater detail, while the required data foundation is largely missing. This pressure is increasingly driven by the growing significance that sustainability plays in public procurement processes. read more

  • Aseptic Fill Finish: Bridging the Gap Between Upstream Precision and Downstream Excellence

    As the sterile fill finish market continues to grow, the role of specialized drug delivery CDMO partnerships must shift from baseline execution to long-term future-proofing. Experienced partners add the highest value by anticipating how shifting global regulatory expectations and future market demands will impact a molecule years after its initial validation. read more

  • Typical and Representative, Part 1

    As technology in endotoxins and pyrogens testing changes, and as the basic research advances our understanding of pyrogenicity, fifty-year-old assumptions and decisions should be revisited, if not challenged. Given that it is neither typical nor representative of potential contaminants, is the current calibrant still an appropriate analyte for endotoxins and pyrogens testing? read more

  • Beyond the Plate: Where Biofluorescent Particle Counting Can Reduce Errors and Strengthen Contamination Control

    The goal is not to eliminate plates. It is to reduce the number of reasons to open or intervene in the isolator. By supplementing traditional environmental monitoring with real-time BFPC, manufacturers can preserve the value of growth-based methods while reducing avoidable interventions—and, consequently, the number of investigations triggered by the monitoring process itself. read more

  • Featured Documentary: A Solid Dosage Future

    While biopharmaceuticals continue to grab much of the limelight in the pharmaceutical industry, the fact is solid dosage products (tablets, capsules, pills, etc.) still account for the majority of medicinal products made worldwide. The reasons for this market share are abundantly clear: patients are familiar with the dosage form and are comfortable using it. In addition, the industry has many decades of experience designing, formulating, testing, manufacturing and packaging solid dosage products. The knowledge base is extensive. read more

  • Watch Video: The Clean Facility of the Future - Advanced Microbiology Techniques for Cleaner Facilities and Purer Products

    Learn about the tools, techniques, services and best practices being used to manufacture high quality products while minimizing contamination and error in the Clean Facility of the Future Documentary. read more